MedTrace Logo

Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow

NCT04264000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-10

No results posted yet for this study

Summary

Ulnar neuropathy at elbow (UNE) is the second common peripheral entrapment neuropathy after carpal tunnel syndrome (CTS). Although many conservative managements of UNE were found, their effectiveness were often unsatisfied without existed guideline. Recently, the perineural injection of 5% dextrose wate (D5W) is a novel management for CTS but its effect for UNE is not obviously as CTS. Hence, it is very important to find another novel injectate for UNE.

Conditions

  • Ulnar Neuropathy at Elbow

Interventions

DRUG

platelet-rich plasma

Ultrasound-guided 3cc PRP injection between medial epicondyle and ulnar nerve

DRUG

5% dextrose

Ultrasound-guided 3cc 5% dextrose injection between medial epicondyle and ulnar nerve

Sponsors & Collaborators

  • Yung-Tsan Wu

    lead OTHER

Principal Investigators

  • Yung-Tsan Wu · Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04264000 on ClinicalTrials.gov